Search results for " angina"

showing 10 items of 117 documents

Advantages of immediate two-dimensional echocardiography in patients with acute cardiac ischemic events

1995

Abstract We hypothesized that the assessment of kinetic alterations on two dimensional echocardiogram (2DE) would provide greater diagnostic information than clinical symptoms and ECG changes only. The study was aimed to determine sensitivity of 2DE in patients with cardiac ischemic events and to improve the indications to thrombolysis. Three-hundred ninety-one patients (87 F; 304 M) hospitalized for suspected acute myocardial infarction (AMI), first episode, within 4 h from the onset of symptoms, suitable for thrombolysis Killip class I–II and with unstable angina (UA), were admitted in the study. Patients had to show ECG changes and alterations of segmentary motion on 2DE performed at ent…

AdultMalemedicine.medical_specialtySystolemedicine.medical_treatmentMyocardial InfarctionMyocardial IschemiaIschemiaInfarctionSensitivity and SpecificityVentricular Function LeftElectrocardiographyFibrinolytic AgentsInternal medicinemedicineHumansThrombolytic TherapyAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassCreatine KinaseAgedKillip classAged 80 and overFirst episodeHeparinVascular diseaseUnstable anginabusiness.industryThrombolysisMiddle Agedmedicine.diseaseIsoenzymesSurvival RateEchocardiographyVentricular Function RightCardiologyFemaleCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Impact of routine angiographic follow-up after angioplasty

1998

Abstract Background There is an ongoing controversy as to whether repeat coronary angiography should be routinely performed after successful percutaneous transluminal coronary angioplasty (PTCA). Methods We examined the 10-year outcome in 400 patients who had or had not undergone an angiographic control 6 months after successful PTCA and a subsequent event-free 6-month period. Our comparison was based on data gathered by questionnaire and telephone interview in 315 patients with (group A) and 85 patients without (group B) a routine 6-month angiographic control. Multivariate analysis (Cox model) was performed to identify predictors of adverse events. Results During the 10-year follow-up peri…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionUnnecessary ProceduresCoronary AngiographyDisease-Free SurvivalSurveys and QuestionnairesInternal medicineAngioplastyHumansMedicineLife Tablescardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAdverse effectAgedProportional Hazards Modelsbusiness.industryProportional hazards modelUnstable anginaMortality rateMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureBypass surgeryCardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryAmerican Heart Journal
researchProduct

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris

1996

Percutaneous transluminal coronary angioplasty is often complicated by thrombotic abrupt vessel closure in patients with unstable angina pectoris. The present multicentre trial was performed to determine the feasibility of two-dose regimens of recombinant hirudin (r-hirudin) compared to standard heparin in patients undergoing coronary angioplasty for unstable angina, and to investigate the effects of the different treatment regimen on markers of coagulation activation. At five participating centres, 61 patients were randomly enrolled in one of two sequential groups of r-hirudin (group 1: 0.3 mg.kg-1 i.v. bolus, 0.12 mg.kg-1.h-1 i.v. infusion; 21 patients; group 2: 0.5 mg.kg-1 i.v. bolus, 0.…

Adultmedicine.drug_classmedicine.medical_treatmentHirudinEnzyme-Linked Immunosorbent AssayAnginaFibrinolytic AgentsmedicineHumansAngina UnstableAngioplasty Balloon CoronaryInfusions IntravenousBlood CoagulationAgedBlood coagulation testDose-Response Relationship Drugmedicine.diagnostic_testHeparinUnstable anginabusiness.industryAnticoagulantThrombinAnticoagulantsPercutaneous coronary interventionHeparinHirudinsMiddle Agedmedicine.diseaseRecombinant ProteinsAnesthesiaPartial Thromboplastin TimeDrug MonitoringCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugPartial thromboplastin timeEuropean Heart Journal
researchProduct

A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent

2015

Non previsto.

Angina Pectoris VariantMaleCoronary angiographymedicine.medical_specialtyTime FactorsVasodilator Agentsmedicine.medical_treatmentCoronary VasospasmPrinzmetal angina coronary artery stenting stent second-generation drug-eluting stent.Coronary AngiographyProsthesis DesignBalloonAnginaAngioplastyInternal medicineRare caseHumansMedicineEverolimusAngioplasty Balloon CoronarySirolimusEverolimusbusiness.industryCoronary StenosisCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareTreatment Outcomemedicine.anatomical_structureDrug-eluting stentCardiologyPrinzmetal angina coronary artery stentingdrug-eluting stentCardiology and Cardiovascular Medicinebusinessmedicine.drugArteryCoronary Artery Disease
researchProduct

Anti-inflammatory and antioxidant effects of ranolazine on primary cultured astrocytes

2014

Because of its ability to block late INa [1], ranolazine is used as an antianginal agent for the treatment of chronic angina pectoris when angina is not adequately controlled by other agents [2]. Besides its cardiovascular effects, ranolazine improves different neuronal functions, and thus its use has been proposed for the treatment of pain and epileptic disorders [3,4]. Since astrocytes are involved in neuronal inflammatory processes, and autoimmune and neurodegenerative diseases [5], we have investigated the antiinflammatory and antioxidant effects of ranolazine in primary cultured astrocytes.

Antioxidantmedicine.drug_classbusiness.industrymedicine.medical_treatmentRanolazineChronic anginaPharmacologymedicine.diseaseCritical Care and Intensive Care MedicineAnti-inflammatoryAnginaPoster Presentationmedicinebusinessmedicine.drugCritical Care
researchProduct

[Diagnosis of coronary microvascualar dysfunction in diabetic patients with cardiac syndrome X: comparison by current methods].

2013

The study population included 208 patients with chest pain and uninjured coronary arteries that we split into two populations: diabetics (72 patients) and non-diabetics (136 patients). We split patients with chest pain and uninjured coronary arteries that had a myocardial scintigraphy into two populations: patients with positive scintigraphy and negative. We calculated, on angiographic images of each patient, stored on suitable digital supports, Timi Frame Count (TFC), Myocardial Blush Grade (MBG) and Total Myocardial Blush Score (TMBS) using the protocol described by Gibson and Yusuf. On the basis of Yusuf's experience we imagined a new index: the Total Timi Frame Count as the sum of the t…

Cardiac syndrome X chest pain coronary angiography diabetes mellitus microcirculation myocardial scintigraphyChest PainMicrocirculationReproducibility of ResultsCoronary DiseaseCoronary AngiographySeverity of Illness IndexElectrocardiographyPredictive Value of TestsRisk FactorsCoronary CirculationExercise TestHumansEmergency Service HospitalRadionuclide ImagingBlood Flow VelocityDiabetic AngiopathiesMicrovascular Angina
researchProduct

Langzeitverlauf über 10 Jahre nach Ballondilatation bei stabiler und instabiler Angina pectoris

2008

OBJECTIVE To assess the cardiac status of patients ten years after percutaneous transluminal coronary artery angioplasty (PTCA). PATIENTS AND METHODS Data of 534 patients (436 men, 98 women; mean age 53.2 +/- 8 years) in whom a PTCA had been performed between 1983 and 1986 were analysed, based on a questionnaire answered 121 +/- 11 months after the initial procedure. At the time of PTCA 184 patients (35%) had unstable angina, 350 (65%) stable angina. RESULTS 116 patients (63%) with unstable angina and 164 (47%) with stable angina had at least one cardiac event after the initial PTCA (repeat PTCA, bypass operation, myocardial infarction, death). None of these events occurred in 68 patients (…

Cardiovascular eventmedicine.medical_specialtyPercutaneousbusiness.industryUnstable anginaGeneral Medicinemedicine.diseasesurgical procedures operativeBypass operationInternal medicineCardiologyMedicineCoronary artery angioplastyIn patientcardiovascular diseasesMyocardial infarctionbusinessCardiac statusDMW - Deutsche Medizinische Wochenschrift
researchProduct

Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month fol…

2008

Background The purpose of this study was to investigate whether the vasodilator response to brachial artery and the presence of carotid lesions may have a prognostic significance in patients with early stages of atherosclerosis. Methods and results Vascular echography was performed to analyze flow-mediated vasodilatation (FMD) at the brachial artery and intima–media thickness (IMT) of carotid arteries in 84 asymptomatic patients. At baseline, we evaluated all the established traditional cardiovascular risk factors. Transient ischemic attack, stroke, effort or unstable angina, acute myocardial infarction, peripheral arterial disease and cerebrovascular and cardiovascular death served as outc…

Carotid Artery DiseasesMalemedicine.medical_specialtyBrachial ArteryAsymptomaticCoronary artery diseaseSex FactorsRisk Factorsmedicine.arteryInternal medicineOdds RatiomedicineHumanscardiovascular diseasesMyocardial infarctionBrachial arteryStrokeAgedUltrasonographyCarotid atherosclerosis Endothelial dysfunction Prognosis Risk factorsUnstable anginabusiness.industryAge FactorsGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareVasodilationCarotid Arteriesmedicine.anatomical_structureBlood pressurecardiovascular systemCardiologyFemaleEndothelium Vascularmedicine.symptomTunica IntimaTunica MediaCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesArteryCoronary Artery Disease
researchProduct

Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia.

2008

This study sought to assess the role of multislice computed tomography (MSCT) in patients with suspected chronic mesenteric ischaemia (CMI). Forty-five patients (29 men; mean age 68) underwent MSCT angiography of the abdomen for suspected CMI (main clinical finding: postprandial abdominal pain). The scan protocol was detectors/collimation 16/0.75 mm; feed 36 mm/s; rotation time 500 ms; increment 0.4 mm; 120-150 mAs and 120 kVp. A volume of 80 ml of contrast material was administered through an antecubital vein (rate 4 ml/s), followed by 40 ml of saline (rate 4 ml/s). Images were analysed on the workstation with different algorithms (axial image scrolling, multiplanar reconstructions, maximu…

Chronic mesenteric ischaemiaAdultMalemedicine.medical_specialtychemical and pharmacologic phenomenacomplex mixturesAbdominal anginaCeliac ArteryIschemiaMesenteric Artery Superiormedicine.arteryparasitic diseasesMSCT angiographymedicineHumansRadiology Nuclear Medicine and imagingIn patientMesenterycardiovascular diseasesSuperior mesenteric arteryMSCT angiography Chronic mesenteric ischaemia Abdominal anginaAbdominal anginaNeuroradiologyAgedAged 80 and overmedicine.diagnostic_testbusiness.industryUltrasoundAngiographynutritional and metabolic diseasesInterventional radiologyGeneral MedicineMiddle Agedbacterial infections and mycosesChronic mesenteric ischaemiaTrunkdigestive system diseasessurgical procedures operativecardiovascular systemFemaleRadiologyCOMPUTED TOMOGRAPHYmedicine.symptombusinessTomography X-Ray Computedtherapeutics
researchProduct

Oral Glycoprotein IIb/IIa Antagonists for Unstable Angina — Is There Still a Chance for the Oral Substances?

2001

The intravenous glycoprotein IIb/IIIa antagonists abciximab, tirofiban and eptifibatide are well accepted for the therapy of patients with unstable angina and/or as concomitant medication during coronary interventions. Despite the fact that these drugs are not used in all patients presenting with unstable angina during coronary interventions, the scientific evidence is overwhelming including the substantial reduction in mortality 3 years after utilisation of abciximab for coronary interventions in patients with unstable angina. In addition to these two indications, intravenous glycoprotein IIb/IIIa antagonists are currently being investigated for use in patients undergoing carotid artery in…

Clinical Trials as Topicmedicine.medical_specialtyUnstable anginaFibrinogen receptorbusiness.industryAdministration OralPlatelet Glycoprotein GPIIb-IIIa ComplexHematologyTirofibanmedicine.diseaseAnginaInternal medicinemedicineAbciximabCardiologyEptifibatideHumansAngina UnstableMyocardial infarctionbusinessStrokePlatelet Aggregation Inhibitorsmedicine.drugThrombosis Research
researchProduct